DIANA VALENCIA: Open Payments
NPI 1417554338 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 26 payments from 13 companies in 2025. Trend: 2023 $227 · 2024 $520 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $217 |
| ABBVIE INC. | 4 | $80 |
| Exact Sciences Corporation | 3 | $58 |
| Novo Nordisk Inc | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Ascensia Diabetes Care Us Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: AIRSUPRA, VRAYLAR, Cologuard Collection Kit, CAPLYTA, Rybelsus, TRELEGY ELLIPTA, FARXIGA, Veozah.
Industry payments across AZ — which companies pay providers there.
